Target intelligence / Profile preview

Myelin oligodendrocyte glycoprotein-reactive autoreactive effector memory T cell (null)

Target
null
Molecular classification
Other (immune cell population; not a protein, receptor, enzyme, etc.)
01

Overview

Myelin oligodendrocyte glycoprotein-reactive autoreactive effector and memory CD4+ and/or CD8+ T cells are populations of T lymphocytes that recognize antigens derived from myelin oligodendrocyte glycoprotein (MOG), a protein found on the outer surface of central nervous system myelin[2][3][6]. These T cells escape central and peripheral tolerance, become activated, and contribute to demyelination by attacking CNS myelin, either directly (by cytotoxicity or cytokine secretion) or indirectly by promoting recruitment of other inflammatory cells and facilitating entry of antibodies and immune mediators[2][4]. They are central to animal models of experimental autoimmune encephalomyelitis and play a pathogenic role in multiple human demyelinating diseases including MS and MOGAD, with CD4+ T cells generally having a dominant role but CD8+ T cells also being involved[1][2][6].

Other names
MOG-reactive T cellsMOG-specific effector memory CD4+ and/or CD8+ T cellsautoimmune T cells targeting MOG
02

Mechanism of action

Suppression of T cell proliferation or function; Depletion of immune cells; Modulation of antibody production

03

Biological functions

Immune responseAutoimmunityInflammatory response
04

Disease associations

Multiple sclerosisMOG antibody-associated disease (MOGAD)Optic neuritisTransverse myelitisDemyelinating diseases of the central nervous system
05

Safety considerations

General immunosuppression risk (infection, malignancy) due to broad targeting of immune cellsRisk of relapse upon withdrawal of therapy
06

Interacting drugs

Immunosuppressive agents (e.g., corticosteroids, rituximab, azathioprine; these act broadly on immune cells, not specifically on MOG-reactive T cells)
07

Biomarkers

Presence of MOG-specific T cells (typically measured ex vivo by proliferation/cytokine assays)MOG-IgG (for MOGAD; not the T cells themselves but related autoimmune marker)

Beyond the preview

Go deeper on Myelin oligodendrocyte glycoprotein-reactive autoreactive effector memory T cell (null).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Myelin oligodendrocyte glycoprotein-reactive autoreactive effector memory T cell (null).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call